Immunising Against Meningococcal Serogroup Y Using Proteins
AssigneeGlaxosmithkline Biologicals SA
InventorsMario Contorni, Marzia Giuliani, Mariagrazia Pizza
Life of this patent
Estimating the term…
Abstract
The invention uses polypeptide antigens and/or OMVs to immunize against serogroups A, C, W135 and Y (and against serogroup Y in particular). Serogroup B polypeptides can achieve this protection, thus permitting a single polypeptide-based vaccine to be used for protecting against all of serogroups A, B, C, W135 and Y.
Claims5
A method of immunising a subject against infection by serogroup Y of Neisseria meningitidis, comprising administering to the subject a composition comprising one or more immunogenic Neisseria polypeptides.
A method of immunising a subject against infection by serogroup Y of Neisseria meningitidis, comprising administering to the subject a composition comprising meningococcal OMVs.
3-4. (canceled)
Dependencies are inferred from the claim text.